[Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán
J
J
Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston.
Kantarjian
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004351:Drug Resistance; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D009363:Neoplasm Proteins; D009364:Neoplasm Recurrence, Local; D014411:Neoplastic Stem Cells / Q000187:drug effects; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D000071156:Promyelocytic Leukemia Protein; D018168:Receptors, Retinoic Acid / Q000235:genetics; D012074:Remission Induction; D014157:Transcription Factors / Q000235:genetics; D014178:Translocation, Genetic; D014212:Tretinoin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D025521:Tumor Suppressor Proteins
D007155:Immunologic Factors; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion; D000071156:Promyelocytic Leukemia Protein; D018168:Receptors, Retinoic Acid; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C070576:PML protein, human; D014212:Tretinoin
Papel del ácido retinoico en el tratamiento de la leucemia promielocítica aguda.